These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11191065)

  • 1. Antiangiogenic chemotherapeutic agents.
    Schirner M
    Cancer Metastasis Rev; 2000; 19(1-2):67-73. PubMed ID: 11191065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models.
    Schirner M; Hoffmann J; Menrad A; Schneider MR
    Clin Cancer Res; 1998 May; 4(5):1331-6. PubMed ID: 9607594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possible role of chemotherapy in antiangiogenic drug resistance.
    Bocci G; Loupakis F
    Med Hypotheses; 2012 May; 78(5):646-8. PubMed ID: 22365648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic strategies and agents in clinical trials.
    Rosen L
    Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic scheduling of lower dose cancer chemotherapy.
    Gately S; Kerbel R
    Cancer J; 2001; 7(5):427-36. PubMed ID: 11693902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current strategies and future directions of antiangiogenic tumor therapy.
    Zhang ZL; Wang JH; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic therapy for the treatment of pediatric solid malignancies.
    Davidoff AM; Kandel JJ
    Semin Pediatr Surg; 2004 Feb; 13(1):53-60. PubMed ID: 14765371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenesis by chemotherapeutic agents.
    Ribatti D; Vacca A; Merchionne F; Presta M
    Mini Rev Med Chem; 2005 Mar; 5(3):313-7. PubMed ID: 15777265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
    Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
    Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
    Wilson PM; LaBonte MJ; Lenz HJ
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineovascular therapy, a novel antiangiogenic approach.
    Shimizu K; Asai T; Oku N
    Expert Opin Ther Targets; 2005 Feb; 9(1):63-76. PubMed ID: 15757482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and future directions for angiogenesis-based cancer therapies.
    Scappaticci FA
    J Clin Oncol; 2002 Sep; 20(18):3906-27. PubMed ID: 12228212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics.
    Fuso Nerini I; Cesca M; Bizzaro F; Giavazzi R
    Chin J Cancer; 2016 Jun; 35(1):61. PubMed ID: 27357621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-tumor target--beneficial site for antiangiogenic cancer therapy?
    Cao Y
    Nat Rev Clin Oncol; 2010 Oct; 7(10):604-8. PubMed ID: 20683436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic cancer treatment: The great discovery and greater complexity (Review).
    Maj E; Papiernik D; Wietrzyk J
    Int J Oncol; 2016 Nov; 49(5):1773-1784. PubMed ID: 27826619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic therapy.
    Albo D; Wang TN; Tuszynski GP
    Curr Pharm Des; 2004; 10(1):27-37. PubMed ID: 14754403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment.
    Gagne P; Akalu A; Brooks PC
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of angiogenesis in cancers.
    Pang RW; Poon RT
    Vasc Health Risk Manag; 2006; 2(2):97-108. PubMed ID: 17319453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.